Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate adjunctive therapy dose-ranging study in infants with refractory partial-onset seizures
2005-001338-33Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of topiramate in epilepsy and focal-onset epileptic seizures (5 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Primary safety and tolerability objective and Primary efficacy endpoint. Started Jun 2005; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsyfocal-onset epileptic seizures
Beyond the preview
Go deeper on 2005-001338-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001338-33.